Merger Agreements in the Pharmaceuticals Industry

476 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AGREEMENT AND PLAN OF MERGER
Merger Agreements
COLLEGIUM PHARMACEUTICAL, INC
Pharmaceuticals
VA
2015
Amendment No. 2 to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc., dated as of...
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2025
Agreement and Plan of Merger, dated as of January 10, 2025, by and among Johnson & Johnson, Fleming Merger Sub, Inc. and Intra-Cellular Therapies, Inc
Merger Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
2025
Agreement and Plan of Merger, dated as of December 29, 2024, by and among Marinus Pharmaceuticals, Inc., Immedica Pharma AB and Matador Subsidiary, Inc
Merger Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
2024
Agreement and Plan of Merger, dated as of December 18, 2024, by and among Vireo WH Merger Sub Inc., Vireo Growth Inc., WholesomeCo, Inc. and Shareholder Representative Services LLC
Merger Agreements
Vireo Health International, Inc.
Pharmaceuticals
2024
Agreement and Plan of Merger, dated as of December 18, 2024, by and among Vireo PR Merger Sub Inc., Vireo PR Merger Sub II Inc., Vireo Growth Inc., NGH Investments, Inc., Proper...
Merger Agreements
Vireo Health International, Inc.
Pharmaceuticals
2024
Agreement and Plan of Merger, dated as of December 18, 2024, by and among Vireo DR Merger Sub Inc., Vireo Growth Inc., Deep Roots Holdings, Inc. and Shareholder Representative...
Merger Agreements
Vireo Health International, Inc.
Pharmaceuticals
2024
Agreement and Plan of Merger and Reorganization, dated December 17, 2024, by and among Cara Therapeutics, Inc., CT Convergence Merger Sub, Inc. and Tvardi Therapeutics, Inc
Merger Agreements
Cara Therapeutics, Inc.
2024
Amendment to the Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of...
Merger Agreements
Revance Therapeutics, Inc.
2024
Termination Agreement, dated as of December 10, 2024 by and between Hepion Pharmaceuticals, Inc., Pharma Two B Ltd. and Pearl Merger Sub, Inc
Merger Agreements
ContraVir Pharmaceuticals, Inc.
2024
Amended and Restated Support Agreement, dated as of December 7, 2024, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and the parties named on Schedule A thereto...
Merger Agreements
Revance Therapeutics, Inc.
2024
Amended and Restated Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of December 7, 2024
Merger Agreements
Revance Therapeutics, Inc.
2024
Fourth Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated November 19, 2024
Merger Agreements
Evofem Biosciences, Inc.
2024
Agreement and Plan of Merger and Reorganization, dated as of November 13, 2024, by and among Pulmatrix, Inc., PCL Merger Sub, Inc., PCL Merger Sub II, LLC and Cullgen Inc
Merger Agreements
Pulmatrix, Inc.
2024
Amendment No. 1 to Agreement and Plan of Merger, dated as of August 7, 2019, by and among Semnur Pharmaceuticals, Inc., Scilex Holding Company, Sigma Merger Sub, Inc., Fortis...
Merger Agreements
Semnur Pharmaceuticals, Inc.
2024
Agreement and Plan of Merger, dated as of March 18, 2019, by and among Scilex Holding Company, Sigma Merger Sub, Inc., Semnur Pharmaceuticals, Inc., Fortis Advisors LLC, solely as...
Merger Agreements
Semnur Pharmaceuticals, Inc.
2024
Agreement and Plan of Merger, dated October 23, 2024, by and among Can B Corp., Nascent Pharma Holdings, Inc. and Nascent Merger Sub
Merger Agreements
Canbiola, Inc.
2024
Agreement and Plan of Merger, dated as of October 14, 2024, by and among Longboard Pharmaceuticals, Inc., H. Lundbeck A/S, Langkawi Corporation and Lundbeck LLC
Merger Agreements
Longboard Pharmaceuticals, Inc.
2024
Third Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated October 2, 2024
Merger Agreements
Evofem Biosciences, Inc.
2024
Second Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated September 6, 2024
Merger Agreements
Evofem Biosciences, Inc.
2024
First Amendment to the Amended and Restated Agreement and Plan of Merger, by and among the Company, Aditxt, Inc. and Adifem, Inc., dated August 16, 2024
Merger Agreements
Evofem Biosciences, Inc.
2024
Merger and Contribution and Share Exchange Agreement, dated as of August 19, 2024, by and among Titan Pharmaceuticals, Inc., TTNP Merger Sub, Inc., KE Sdn. Bhd., and BSKE Ltd
Merger Agreements
TITAN PHARMACEUTICALS INC
2024
Side Letter Agreement, dated August 12, 2024, by and by and among Citius Pharmaceuticals, Inc., Citius Oncology, Inc., TenX Keane Acquisition and TenX Merger Sub, Inc
Merger Agreements
Citius Pharmaceuticals, Inc.
2024
Agreement and Plan of Merger, by and among Crown Laboratories, Inc., Reba Merger Sub, Inc. and Revance Therapeutics, Inc. dated as of August 11, 2024
Merger Agreements
Revance Therapeutics, Inc.
2024
Agreement and Plan of Merger, dated as of July 28, 2024, by and among the Company, Ironshore Therapeutics Inc. and Shareholder Representative Services LLC
Merger Agreements
COLLEGIUM PHARMACEUTICAL, INC
2024
Agreement and Plan of Merger, dated as of July 19, 2024, by and among the Company, Parent and Merger Sub
Merger Agreements
ContraVir Pharmaceuticals, Inc.
2024
Amended and Restated Plan of Merger, by and between the Company, Aditxt, Inc. and Adifem, Inc
Merger Agreements
Evofem Biosciences, Inc.
2024
Agreement and Plan of Merger, dated June 25, 2024, by and among Insud Pharma, S.L., Exeltis Project, Inc. and the Company
Merger Agreements
AGILE THERAPEUTICS INC
2024
Agreement and Plan of Merger
Merger Agreements
ALIMERA SCIENCES INC
2024
Agreement and Plan of Merger dated June 21, 2024, by and among ANI Pharmaceuticals, Inc., ANIP Merger Sub INC. and Alimera Sciences, Inc
Merger Agreements
ANI Pharma Inc
2024
Fourth Amendment to the Agreement and Plan of Merger dated as of May 2, 2024, by and among Aditxt, Inc., Adifem, Inc. and Evofem Biosciences, Inc
Merger Agreements
Evofem Biosciences, Inc.
2024
Agreement and Plan of Merger and Reorganization, dated March
Merger Agreements
Cerecor Inc.
2024
Agreement and Plan of Merger and Reorganization, dated March 24, 2024, by and among Nuvation Bio Inc., AnHeart Therapeutics Ltd., Artemis Merger Sub I, Ltd. and Artemis Merger Sub...
Merger Agreements
Panacea Acquisition Corp
2024
Agreement and Plan of Merger, dated as of March 24, 2024, by and among Landos Biopharma, Inc., AbbVie Inc., Bespin Subsidiary, LLC and Bespin Merger Sub, Inc
Merger Agreements
Landos Biopharma, Inc.
2024
Agreement and Plan of Merger, dated March 4, 2024, by and between MyMD Pharmaceuticals, Inc., a New Jersey corporation, and MyMD Pharmaceuticals, Inc., a Delaware corporation
Merger Agreements
Akers Biosciences, Inc.
2024
Third Amendment to Agreement and Plan of Merger dated as of February 29, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc
Merger Agreements
Evofem Biosciences, Inc.
2024
Agreement and Plan of Merger, dated as of February 28, 2024, by and among Societal CDMO, Inc., CoreRx, Inc. and Cane Merger Sub, Inc
Merger Agreements
Recro Pharma, Inc.
2024
Agreement and Plan of Merger, dated February 25, 2024, by and among NGM Biopharmaceuticals, Inc., Atlas Neon Parent, Inc. and Atlas Neon Merger Sub, Inc
Merger Agreements
NGM BIOPHARMACEUTICALS INC
2024
Agreement and Plan of Merger, dated as of February 11, 2024, by and among CymaBay Therapeutics, Inc., Gilead Sciences, Inc. and Pacific Merger Sub, Inc
Merger Agreements
CymaBay Therapeutics, Inc.
2024
Agreement and Plan of Merger, dated as of February 5, 2024, by and among the Company, Parent and Merger Sub
Merger Agreements
Catalent Inc
2024
Second Amendment to the Merger Agreement, dated January 30, 2024
Merger Agreements
Evofem Biosciences, Inc.
2024